CPC A61K 31/13 (2013.01) [A61K 9/0019 (2013.01); A61K 45/06 (2013.01)] | 20 Claims |
1. A method of treating traumatic brain injury (TBI) in a human subject comprising intravenously administering a composition consisting of a pharmacologically effective amount of amantadine or a pharmaceutically acceptable salt thereof in sterile water and wherein the composition is free of any other excipients, the composition has a volume of about 100 ml to about 1000 ml and the composition is administered once or twice daily at a daily dose of about 200 mg to about 400 mg amantadine or a pharmaceutically acceptable salt thereof at a rate of about 15 mg/hr to about 135 mg/hr.
|